China National Medicines Corporation Ltd.’s Net Profit Rose 2.4% in First Three Quarters of 2023

China National Medicines Corporation Ltd. (国药集团药业股份有限公司) (600511.SH) reported a net profit of 1.6 billion yuan in the first three quarters of 2023, up 2.4% year-on-year.

Meanwhile, the company posted 36.5 billion yuan in revenue, up 5.8% year-on-year.

At the end of the reporting period, it had 31.6 billion yuan in total assets and 14.8 billion yuan in total liabilities, with a liability-to-asset ratio of 46.9%.